Create an Account - Increase your productivity, customize your experience, and engage in information you care about.
LAKE FOREST, California, Jan. 27, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, introduces Evoke, a breakthrough non-invasive solution for facial remodeling.
Evoke is the first hands-free device for the face and submental area cleared by the FDA. This advanced radiofrequency-based platform addresses patient aesthetic concerns with uniform and controlled heating of the skin and subdermal tissue.
Dr. Michael Kreindel, InMode Chief Technology Officer, and inventor of Evoke commented, "The idea of a facial hands-free treatment has been circulating in the market for about 8 years. I’m proud that InMode, after years of research and development, is the first company to bring this solution to patients worldwide."